Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2012
08/30/2012US20120220453 Pesticidal compostions and processes related thereto
08/30/2012US20120219522 Substituted quinoline compounds and methods of use
08/30/2012US20120217449 Materials for electronic devices
08/30/2012CA2827567A1 Novel compounds as histamine h3 receptor ligands
08/30/2012CA2827372A1 Glycine transporter-inhibiting substances
08/30/2012CA2827072A1 Diaminopyrimidine derivatives and processes for the preparation thereof
08/30/2012CA2827030A1 Diaminopyrimidine derivatives and processes for the preparation thereof
08/30/2012CA2824350A1 (pyridin-4-yl)benzylamides as allosteric modulators of alpha 7 nachr
08/30/2012CA2820767A1 Asymmetric ureas and medical uses thereof
08/29/2012EP2492276A1 Metal complex, polymer, and element obtained using same
08/29/2012EP2492266A1 5-hydroxypyrimidine-4-carboxamide derivative
08/29/2012EP2492262A1 Fused heterocyclic compound and thrombopoietin receptor activator
08/29/2012EP2491028A1 Indazole and pyrazolopyridine compounds as ccr1 receptor antagonists
08/29/2012EP2491027A1 Salts of imatinib with tartaric acids
08/29/2012EP2491026A1 Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators
08/29/2012EP2491025A1 Azaazulene compounds
08/29/2012EP2491024A1 Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines
08/29/2012EP2491022A1 Diazepam derivatives as modulators of chemokine receptors
08/29/2012EP2490537A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
08/29/2012EP2490529A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
08/29/2012CN102652462A Method for manufacturing organic electroluminescent element, organic electroluminescent element, display device and illuminating device
08/29/2012CN102652128A 4 -oxo- iH -quinoline- 3 - carboxamides as modulators of ATP -binding cassette transporters
08/29/2012CN102649904A Iridium-containing organic electroluminescent material, preparation method thereof and organic electroluminescent device
08/29/2012CN102649787A (benzimidazole-2-yl)pyridine derivative and application thereof to preparation of anticoagulant medicines
08/29/2012CN102649786A Preparation method for 2, 4-diamino-5-(8-dimethylamino-7-methyl-5-quinolyl Methyl)-2, 4-(1H and 3H) pyrimidine
08/29/2012CN102649785A Novel preparation method for Beta crystal type of lmatinib methane sulfonate
08/29/2012CN102649778A Quinazoline derivative and purposes thereof in preparing antineoplastic drugs
08/29/2012CN101772495B Fungicide 2-pyridyl-methylene-thio carboxamide or 2-pyridyl-methylene-N-substituted carboximidamide derivatives
08/29/2012CN101747256B Blue color emitting compound and organic light emitting diode comprising the same
08/29/2012CN101497605B Benzimidazole derivative containing alkoxy substituted pyridine
08/29/2012CN101429232B Hcv protease inhibitors
08/29/2012CN101163684B Quinazoline derivative having tyrosine kinase inhibitory activity
08/29/2012CN101155789B 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
08/29/2012CN101155786B N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
08/28/2012US8252929 8-carboxamido-2,6-methano-3-benzazocines
08/28/2012US8252926 Process for the preparation of imatinib base
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012US8252817 Dipyridyl-dihydropyrazolones and their use
08/28/2012US8252815 Nociceptin analogs
08/28/2012US8252814 Agents and crystals for improving excretory potency of urinary bladder
08/28/2012US8252806 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-propylamine; 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-(4-morpholin-4-yl-phenyl)-amine; respiratory diseases, epilepsy, convulsions, seizures, gastrointestinal dysfunction, ischaemia, psychosis, schizophrenia, anxiety, depression, Alzheimer's disease
08/28/2012US8252803 Piperidine derivatives
08/28/2012US8252800 Protein tyrosine kinase inhibitors
08/28/2012US8252793 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
08/28/2012US8252783 Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
08/28/2012US8252782 Monocarbams
08/28/2012US8252781 1,2-diazetidin-3-one derivatives and drugs containing same
08/28/2012US8252723 Substituted 1-(3-pyridinyl)pyrazol-4-ylacetic acids, processes for their preparation and their use as herbicides and plant growth regulators
08/28/2012CA2671744C Compounds and compositions as protein kinase inhibitors
08/28/2012CA2656079C Cyclic amine compound
08/28/2012CA2651378C Fxr agonists
08/28/2012CA2598224C Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol
08/28/2012CA2570559C Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation
08/28/2012CA2553715C Anthranilamide compounds, process for their production and pesticides containing them
08/23/2012WO2012112969A1 Aminoindane compounds and use thereof in treating pain
08/23/2012WO2012112946A1 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
08/23/2012WO2012112853A1 Four coordinated platinum and palladium complexes with geometrically distorted charge transfer state and their applications in light emitting devices
08/23/2012WO2012111995A1 Oxime derivatives as gpr119 agonists
08/23/2012WO2012111462A1 Organic electroluminescence element and illumination device
08/23/2012WO2012111017A1 3-arylethynyl substituted quinazolinone compounds
08/23/2012WO2012110945A1 Carbazole end capped bipyridine compounds and process for preparation thereof
08/23/2012WO2012110774A1 Selective fak inhibitors
08/23/2012WO2012110773A1 Fak inhibitors
08/23/2012WO2012094462A3 Heterocyclic compounds for the inhibition of pask
08/23/2012WO2012090177A3 Cannabinoid receptor modulators
08/23/2012WO2012089633A9 Novel pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
08/23/2012WO2012074249A3 Novel purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against raf kinase, containing same as active ingredient
08/23/2012US20120215003 Process for the resolution of omeprazole
08/23/2012US20120214996 Compounds useful against kinetoplastideae parasites
08/23/2012US20120214993 Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component
08/23/2012US20120214991 Indenone Derivative and Pharmaceutical Composition Comprising Same
08/23/2012US20120214990 Quinolinones and quinoxalinones as antibacterial composition
08/23/2012US20120214962 Monomers, Oligomeric Complexes, Coordination Polymers, and Methods for Their Preparation and Use
08/23/2012US20120214849 Dual-acting antihypertensive agents
08/23/2012US20120214847 2-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
08/23/2012US20120214837 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
08/23/2012US20120214823 Novel compounds that are erk inhibitors
08/23/2012US20120214817 Urotensin ii receptor antagonists
08/23/2012US20120214815 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
08/23/2012US20120214809 Aminoindane Compounds and Use Thereof in Treating Pain
08/23/2012US20120214803 Novel Sulfonaminoquinoline Hepcidin Antagonists
08/23/2012US20120214800 Organic Compounds
08/23/2012US20120214799 Kinase inhibitors
08/23/2012US20120214790 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
08/23/2012US20120214789 Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists
08/23/2012US20120214786 New compounds
08/23/2012US20120214783 Viral polymerase inhibitors
08/23/2012US20120214766 Cannabinoid receptor modulators
08/23/2012US20120214762 6,5-heterocyclic propargylic alcohol compounds and uses therefor
08/23/2012US20120214735 Acetamide derivatives as glucokinase activators, their process and medicinal applications
08/23/2012US20120214253 Macrocyclic hopo chelators
08/23/2012US20120213807 Neprilysin inhibitors
08/23/2012US20120213806 Neprilysin inhibitors
08/23/2012US20120213795 Compositions and methods for inhibition of the jak pathway
08/23/2012US20120213791 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
08/23/2012US20120213758 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
08/23/2012US20120213733 Anti-infective agents and uses thereof
08/23/2012US20120213729 Compounds for the Treatment of Hepatitis C
08/23/2012US20120213703 Radiolabelled pde10 ligands
08/23/2012US20120211743 BENZO[k]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME
1 ... 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 ... 1080